All strengths of MST Continus® prolonged release granules for oral suspension are being permanently discontinued during 2021 due to difficulty sourcing a key excipient.
Alternative morphine presentations, both prolonged release and immediate release, remain available and will be able to support increased demand.
This alert contains further information and action for providers.
Please note that no response is required via the CAS website to this alert.